Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analytical Treatment Interruption in a Patient With HIV Post Allogeneic Stem Cell Transplantation From a CCR5 delta32 Homozygous Donor

NCT06582797 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.

NCT NCT06582797
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06582797 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analytical Treatment Interruption in a Patient With HIV Post Allogeneic Stem Cell Transplantation From a CCR5 delta32 Homozygous Donor
Lead sponsor
University of Kansas Medical Center
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2024
Completion date
September 30, 2034
Enrollment
10 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection